Why does pregnancy alter thyroid hormone dynamics, and what monitoring is recommended for a pregnant patient with diabetes?

• A. Increased thyroid-binding globulin raises total hormone levels; monitor TSH and free T4; adjust treatment to maintain euthyroid state while managing diabetes and monitor perinatal outcomes.
• B. Thyroid hormone dynamics do not change in pregnancy; monitor only glucose.
• C. Thyroid-binding globulin decreases; monitoring is unnecessary.
• D. Monitor only TSH and ignore free T4.

Answer: (A)

Pregnancy changes thyroid hormone dynamics mainly because estrogen raises thyroid-binding globulin (TBG) levels. More TBG means more thyroid hormone gets bound in the blood, which increases total T4 and T3 but doesn’t necessarily raise the amount of free (unbound) hormone. The body compensates by making more thyroid hormone, so free T4 and free T3 stay within the normal range for most women. In early pregnancy the placenta produces hCG, which can act briefly like TSH and lower maternal TSH, adding another layer of fluctuation. Because these shifts affect how thyroid status is measured and interpreted, monitoring focuses on the active, unbound hormone and a sensitive index of thyroid function.

In a pregnant patient with diabetes, it’s important to keep the thyroid status euthyroid because thyroid hormones influence metabolism and fetal development, and thyroid dysfunction can alter pregnancy outcomes and glucose needs. The best approach is to monitor TSH along with free T4 (using trimester-specific reference ranges) and adjust treatment to maintain a euthyroid state. This often means adjusting thyroid medication dosing if hypothyroid (to normalize TSH and free T4) or modifying antithyroid therapy if hyperthyroid, all while continuing careful diabetes management and watching for perinatal outcomes such as fetal growth and risk of complications.